Hykes Andrew's Form 4 filing
Inari Medical, Inc. (NARI) · filed Apr 5, 2022
- Accession no.
- 0001562180-22-003258
- Filed
- Apr 5, 2022
- Trade date
- Apr 1, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions. Open-market sales total $911.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hykes AndrewCIK 0001806431 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 | Common Stock | FTax withholdingDisposed | −347 | $90.92 | −$31,549.24 | 167,630 | Direct | |
| Apr 1, 2022 | Common Stock | FTax withholdingDisposed | −646 | $90.92 | −$58,734.32 | 166,984 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −2,607 | $89.76F4 | −$234,004.32 | 164,377 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −1,020 | $90.73F5 | −$92,544.6 | 163,357 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −1,373 | $91.86F6 | −$126,123.78 | 161,984 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −3,394 | $91.63F7 | −$310,992.22 | 158,590 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −1,606 | $92.10F8 | −$147,912.6 | 156,984 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
This transaction was executed in multiple trades at prices ranging from $89.23 to $90.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $90.30 to $91.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $91.31 to $92.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $90.99 to $91.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $92.00 to $92.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.